Survival analysis of liver metastases from gastroesophageal junction adenocarcinoma
gastroesophageal junction adenocarcinoma
LIVER METASTASES, GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Using R software v4.3.0, we performed a 1:3 propensity score matching of patients with gastroesophageal junction adenocarcinoma based on the presence or absence of liver metastases, and finally, 221 patients who had liver metastases were matched with 471 patients without liver metastases. The median follow-up for the pre-and post-PSM cohorts was 22 months (interquartile range: 10–44 months) and 11 months (interquartile range: 5–22 months), respectively. As shown in Table Kaplan–Meier curves of the pre- and post-PSM cohort. Kalpan–Meier curves of (